During a routine autopsy of a 72-year-old man with a 10-year history of myasthenia gravis, histological examination of the neuromuscular junction reveals the most common pathological finding in this condition. Which of the following best describes this finding?

Explanation

## Pathological Changes at the NMJ in Myasthenia Gravis ### Structural Alterations in Seropositive MG **Key Point:** The most characteristic and common pathological finding in myasthenia gravis is **flattening and simplification of the postsynaptic membrane** with marked reduction or loss of the normal junctional folds (plicae). This is the hallmark ultrastructural change seen on electron microscopy. ### Mechanism of Postsynaptic Damage **High-Yield:** The pathological sequence in anti-AChR antibody-mediated MG: 1. **Antibody binding** → Anti-AChR IgG binds to acetylcholine receptors on the postsynaptic membrane 2. **Complement activation** → Classical pathway activation (C1q binding) 3. **Membrane attack complex formation** → C5b-C9 deposition 4. **Postsynaptic destruction** → Lysis and loss of the postsynaptic membrane architecture 5. **Junctional fold loss** → Flattening of the normally highly folded postsynaptic membrane ### Electron Microscopy Findings | Finding | Normal NMJ | MG (Seropositive) | |---------|-----------|-------------------| | **Junctional folds** | Deep, regular plicae | Flattened, simplified, reduced | | **Postsynaptic density** | Electron-dense, organized | Sparse, disorganized | | **AChR density** | ~10,000/μm² | ~5,000/μm² (50% reduction) | | **Synaptic cleft** | Normal width | Widened | | **Presynaptic terminal** | Normal morphology | Usually normal (early stages) | ### Clinical Correlation **Clinical Pearl:** The loss of junctional folds is functionally significant because: - Junctional folds normally **amplify the postsynaptic potential** by increasing the surface area for AChR distribution - Flattening reduces the **safety factor** of neuromuscular transmission - Even normal amounts of acetylcholine release become insufficient to reach threshold for muscle action potential - This explains why MG patients fatigue with repetitive stimulation ("decremental response" on repetitive nerve stimulation testing) ### Comparison with Other NMJ Disorders ```mermaid flowchart TD A[NMJ Pathology]:::outcome --> B{Antibody Target?}:::decision B -->|Anti-AChR| C[Postsynaptic flattening]:::outcome B -->|Anti-MuSK| D[Presynaptic abnormality + postsynaptic loss]:::outcome B -->|None - Genetic| E[Presynaptic dysfunction]:::outcome C --> F[Junctional fold loss]:::action D --> G[Reduced acetylcholine release]:::action E --> H[Reduced vesicle mobilization]:::action ``` **Mnemonic for MG Pathology — POST:** - **P**ostsynaptic membrane flattening - **O**ccurs via complement activation - **S**implification of junctional folds - **T**herapy targets antibodies and complement ### Why This Finding Is Most Common In seropositive MG (85% of generalized cases), complement-mediated destruction of the postsynaptic membrane is the primary pathological mechanism. This leads to the characteristic flattening and simplification of junctional folds, which is the most frequently observed ultrastructural abnormality on electron microscopy.